Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy

NurPhoto/NurPhoto via Getty Images In 2023, it was the Yahoo Finance ‘Company of the Year’; Lars Fruergaard Jørgensen was the FT ‘CEO of the Year’; its stock rose ~53% to become the largest company in Europe by market capitalization; and the Danish government had to provide its official figures adjusted to exclude its impact. What a year Novo Nordisk (NVO) has had. This was driven by its novel GLP-1 therapeutics, Wegovy and Ozempic, which have become household names attracting a buzz deafened only by th ...